A Long Term Safety Study of Degarelix in Patients With Prostate Cancer

NCT00967018 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
77
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Ferring Pharmaceuticals